For the Inventor, By the Inventor

Enter inventor name

Montreal, Canada

Karen Thibaudeau

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 1

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 509(Granted Patents)

Location History:

Montreal, CA (2002 - 2010)
Quebec, CA (2011)
Rosemere, CA (2007 - 2022)

Company Filing History:

Conjuchem, Inc.

Conjuchem Biotechnologies Inc.

Prometic Biotherapeutics, Inc.

Advanced Diagnostics and Discovery

Years Active: 2002-2022

Loading Chart...

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11291711 - Plasminogen replacement therapy for plasminogen-deficiency (2022-04-05),

2. 8039432 - Method of treatment of diabetes and/or obesity with reduced nausea side effect (2011-10-18),

3. 7982018 - Modified corticotropin releasing factor peptides and uses thereof (2011-07-19),

4. 7906482 - Anti-obesity agents (2011-03-15),

5. 7741286 - Long lasting anti-angiogenic peptides (2010-06-22),

6. 7737251 - Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders (2010-06-15),

7. 7601691 - Anti-obesity agents (2009-10-13),

8. 7256253 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2007-08-14),

9. 7144854 - Long lasting anti-angiogenic peptides (2006-12-05),

10. 7112567 - Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders (2006-09-26),

11. 6887470 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-05-03),

12. 6849714 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-02-01),

13. 6440417 - Antibodies to argatroban derivatives and their use in therapeutic and diagnostic treatments (2002-08-27),

Hello! How can I assist you today regarding innovations, inventions, inventors, patent attorneys, assignees, or patents?

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…